Correlation Between Small Pharma and Ascletis Pharma
Can any of the company-specific risk be diversified away by investing in both Small Pharma and Ascletis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Small Pharma and Ascletis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Small Pharma and Ascletis Pharma, you can compare the effects of market volatilities on Small Pharma and Ascletis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Small Pharma with a short position of Ascletis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Small Pharma and Ascletis Pharma.
Diversification Opportunities for Small Pharma and Ascletis Pharma
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Small and Ascletis is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Small Pharma and Ascletis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascletis Pharma and Small Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Small Pharma are associated (or correlated) with Ascletis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascletis Pharma has no effect on the direction of Small Pharma i.e., Small Pharma and Ascletis Pharma go up and down completely randomly.
Pair Corralation between Small Pharma and Ascletis Pharma
If you would invest 25.00 in Ascletis Pharma on November 4, 2024 and sell it today you would lose (1.00) from holding Ascletis Pharma or give up 4.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 0.4% |
Values | Daily Returns |
Small Pharma vs. Ascletis Pharma
Performance |
Timeline |
Small Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Ascletis Pharma |
Small Pharma and Ascletis Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Small Pharma and Ascletis Pharma
The main advantage of trading using opposite Small Pharma and Ascletis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Small Pharma position performs unexpectedly, Ascletis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascletis Pharma will offset losses from the drop in Ascletis Pharma's long position.Small Pharma vs. Cellectis SA | Small Pharma vs. Biotron Limited | Small Pharma vs. Resverlogix Corp | Small Pharma vs. Covalon Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |